# Phase 4C: Orthosis Design Validation & Comparison Report

## Executive Summary

**Top Recommendation: Design Rank 10**
- Composite Score: `0.780`
- Clinical Use: High support (therapeutic/intensive) | Moderate mobility (functional support) | Lightweight (efficient fabrication) | FAILS one or more FEA checks [REVIEW]

Total Designs Analyzed: **11**

## Design Comparison Matrix

| Rank | Score | Support | Movement | Efficiency | Fabric | Voxels | Weight (g) | FEA | Recommendation |
|------|-------|---------|----------|------------|--------|--------|------------|-----|----------------|
| 10 | 0.780 | 88.9% | 46.9% | 87.8% | 100.0% | 49 | 0.47 | FAIL | High support (therapeutic/intensive) | M... |
| 1 | 0.780 | 85.9% | 47.2% | 92.5% | 100.0% | 30 | 0.29 | FAIL | High support (therapeutic/intensive) | M... |
| 3 | 0.780 | 85.9% | 47.2% | 92.5% | 100.0% | 30 | 0.29 | FAIL | High support (therapeutic/intensive) | M... |
| 8 | 0.780 | 85.9% | 47.2% | 92.5% | 100.0% | 30 | 0.29 | FAIL | High support (therapeutic/intensive) | M... |
| 11 | 0.776 | 88.4% | 51.5% | 81.8% | 100.0% | 73 | 0.70 | FAIL | High support (therapeutic/intensive) | M... |
| 7 | 0.772 | 87.6% | 49.6% | 83.2% | 100.0% | 67 | 0.64 | FAIL | High support (therapeutic/intensive) | M... |
| 9 | 0.767 | 86.8% | 47.7% | 84.2% | 100.0% | 63 | 0.60 | FAIL | High support (therapeutic/intensive) | M... |
| 5 | 0.767 | 85.9% | 49.0% | 84.2% | 100.0% | 63 | 0.60 | FAIL | High support (therapeutic/intensive) | M... |
| 2 | 0.767 | 86.1% | 49.0% | 83.8% | 100.0% | 65 | 0.62 | FAIL | High support (therapeutic/intensive) | M... |
| 4 | 0.767 | 86.6% | 48.3% | 83.5% | 100.0% | 66 | 0.63 | FAIL | High support (therapeutic/intensive) | M... |

## FEA Validation Results

| Rank | Max Stress (MPa) | Peak Strain | Max Deflection (mm) | Support Eff. | Pass |
|------|-----------------|-------------|---------------------|--------------|------|
| 10 | 36.00 | 0.0112 | 0.04 | 0.625 | FAIL |
| 1 | 36.00 | 0.0112 | 0.04 | 0.451 | FAIL |
| 3 | 36.00 | 0.0112 | 0.04 | 0.451 | FAIL |
| 8 | 36.00 | 0.0112 | 0.04 | 0.451 | FAIL |
| 11 | 36.00 | 0.0112 | 0.04 | 0.768 | FAIL |
| 7 | 36.00 | 0.0112 | 0.04 | 0.738 | FAIL |
| 9 | 36.00 | 0.0112 | 0.04 | 0.716 | FAIL |
| 5 | 36.00 | 0.0112 | 0.04 | 0.716 | FAIL |
| 2 | 36.00 | 0.0112 | 0.04 | 0.727 | FAIL |
| 4 | 36.00 | 0.0112 | 0.04 | 0.733 | FAIL |

## Clinical Recommendations

### For Maximum Support (Therapeutic)
- **Rank 10**: High support (therapeutic/intensive) | Moderate mobility (functional support) | Lightweight (efficient fabrication) | FAILS one or more FEA checks [REVIEW]
- **Rank 1**: High support (therapeutic/intensive) | Moderate mobility (functional support) | Ultra-lightweight (minimal print time) | FAILS one or more FEA checks [REVIEW]
- **Rank 3**: High support (therapeutic/intensive) | Moderate mobility (functional support) | Ultra-lightweight (minimal print time) | FAILS one or more FEA checks [REVIEW]

### For Lightweight Daily Wear